RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
A Phase I Study of Reduced Intensity Conditioning Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis A Phase I Study of Reduced Intensity Conditioning Allogeneic Bone Marrow Transplant With Post-transp ...
Systemic Sclerosis
Biological: RIC alloBMT w PTCy in refractory SSc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins